Elicio Therapeutics Inc
Elicio Therapeutics Inc (ELTX) Unusual Options Activity Today
ELTX options volume power reached 0.09x on the previous trading day. The highest reading was on the $2.5 CALL expiring 2027-05-21.
Read more
Checking ELTX unusual options activity helps you spot when traders are making outsized bets on Elicio Therapeutics Inc before the broader market catches on. Elicio Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ELTX unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ELTX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ELTX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ELTX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers.
The company is headquartered in Boston, Massachusetts.
Catalysts rarely arrive without a footprint, and ELTX unusual options activity is often where that footprint shows up first. Our scanner tracks Elicio Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ELTX unusual options volume on the call side or chasing put sweeps, Elicio Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 2.50 | — | 0.15 | 0.15 | 208% | 5 | 101 | 4.95% |
| 5.00 | — | 0.05 | 0.05 | 292% | 0 | 16 | 0.00% |
| 7.50 | — | 5.00 | 5.00 | 1,000% | 5 | 0 | — |
| 2.50 | 0.10 | 4.30 | 2.20 | 1,000% | 0 | 156 | 0.00% |
| 5.00 | 0.70 | 5.50 | 3.10 | 49% | 0 | 0 | — |
| 7.50 | 3.10 | 8.00 | 5.55 | 53% | 0 | 0 | — |
As of September 28, 2026
Spot unusual options activity before it moves
Track ELTX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→